A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer
Clinical trial NCT00121628 · COMPLETED
Trial details
- NCT number
- NCT00121628
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2006-11-01
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.